Calendar Atea Pharmaceuticals, Inc.

Equities

AVIR

US04683R1068

Real-time Estimate Cboe BZX 11:58:03 2024-04-23 am EDT 5-day change 1st Jan Change
3.775 USD +2.86% Intraday chart for Atea Pharmaceuticals, Inc. +0.94% +23.77%

Chart calendar Atea Pharmaceuticals, Inc.

24edd67fd3bce53e8b00bfa42cf8f4.naFMoXiEBZn-OobbbGdcVzsFmCbtggMvaP5-Aa6QvEY.6cU1ljO2ffq2VNSVCSBkbwwy3k250lkeLqwhePSg1mvK5i_4GvFAq7oX0w~eca10fca49d7519b3ee88ecd261ae216

Upcoming events on Atea Pharmaceuticals, Inc.

2024-05-07 Q1 2024 Earnings Release (Projected)
2024-08-06 Q2 2024 Earnings Release (Projected)
2024-11-05 Q3 2024 Earnings Release (Projected)
2025-03-03 Q4 2024 Earnings Release (Projected)

Past events on Atea Pharmaceuticals, Inc.

2024-02-28 04:30 pm Q4 2023 Earnings Call
2024-02-28 04:05 pm Q4 2023 Earnings Release
2024-01-10 01:30 pm JPMorgan Healthcare Conference
2023-11-29 03:00 pm Evercore ISI HealthCONx Conference
2023-11-15 06:00 am Jefferies London Healthcare Conference
2023-11-10 01:00 pm American Association for the Study of Liver Diseases Conference - Poster Number: 1861-A
2023-11-10 01:00 pm American Association for the Study of Liver Diseases Conference - Poster Number: 1879-A
2023-11-10 01:00 pm American Association for the Study of Liver Diseases Conference - Poster Number: 1861-A
2023-11-08 04:30 pm Q3 2023 Earnings Call
2023-11-08 04:05 pm Q3 2023 Earnings Release
2023-09-13 10:10 am Morgan Stanley Global Healthcare Conference
2023-08-08 04:30 pm Q2 2023 Earnings Call
2023-08-08 04:05 pm Q2 2023 Earnings Release
2023-06-16 09:00 am Annual General Meeting
2023-06-08 02:00 pm Jefferies Global Healthcare Conference
2023-05-08 04:30 pm Q1 2023 Earnings Call
2023-05-08 04:05 pm Q1 2023 Earnings Release
2023-04-17 06:00 am European Congress of Clinical Microbiology & Infectious Diseases Conference - Poster Number: P2941
2023-04-17 06:00 am European Congress of Clinical Microbiology & Infectious Diseases Conference - Poster Number: P2629
2023-03-16 12:20 pm Antiviral Research International Conference - Oral Presentation #047

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
0,00


48,6
147
-66.84%
351
259
35.65%
0,00
0,00
-
0,00
0,00
-

0,00

EBITDA
Million USD
Released
Forecast
Spread
0,00


-11,0
68,8
-116.01%
138
57,4
141.25%
-130
-115
-13.43%
-164
-138
-18.24%

-210

EBIT
Million USD
Released
Forecast
Spread
0,00


-11,0
54,9
-120.1%
138
87,5
58.11%
-131
-119
-10.14%
-164
-146
-12.06%

-213

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
0,00


-10,9
-62,0
82.34%
139
65,6
111.38%
-119
-121
1.03%
-135
-138
1.92%

-231

Net income
Million USD
Released
Forecast
Spread
-14,0


-10,9
-62,4
82.47%
121
20,0
506.36%
-116
-120
3.61%
-136
-138
1.63%

-231

EPS
USD
Released
Forecast
Spread
-1,39


-0,51
-1,45
64.91%
1,37
0,21
542.8%
-1,39
-1,43
2.63%
-1,63
-1,66
1.61%

-2,76

Announcement Date19/06/2030/03/2128/02/2228/02/2328/02/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales
Million USD
Released
Forecast
Spread
192
85,7
124.18%
0,00
3,33
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-

0,00


0,00


0,00


0,00

EBITDA
Million USD
Released
Forecast
Spread
121
-34,0
456.44%
-42,2
-73,0
42.24%
-32,3
-47,0
31.38%
-16,2
-37,0
56.28%
-39,8
-44,0
9.56%
-41,5
-51,0
18.7%
-35,1
-52,0
32.44%
-40,7
-49,0
16.98%
-46,5
-50,0
7.06%

-59,0


-70,0


-75,0


-79,0

EBIT
Million USD
Released
Forecast
Spread
121
48,4
150.58%
-42,2
-54,9
23.14%
-32,3
-45,1
28.37%
-16,3
-36,1
54.96%
-39,9
-39,6
-0.65%
-41,6
-46,6
10.75%
-35,2
-47,8
26.26%
-40,8
-44,1
7.55%
-46,6
-47,4
1.73%

-54,6


-62,2


-65,1


-68,6

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
121
48,4
150.55%
-42,1
-54,9
23.29%
-31,2
-45,1
30.74%
-11,9
-35,1
66.13%
-34,3
-35,6
3.75%
-35,3
-42,0
15.99%
-27,9
-41,7
32.99%
-32,9
-37,9
13.09%
-38,8
-41,5
6.5%

-49,5


-57,5


-60,5


-63,9

Net income
Million USD
Released
Forecast
Spread
117
15,9
638.07%
-42,1
-46,4
9.32%
-31,3
-43,4
27.88%
-8,07
-37,1
78.25%
-34,4
-37,6
8.5%
-35,5
-41,8
15.13%
-28,2
-40,5
30.39%
-33,1
-39,9
16.98%
-39,2
-41,3
5.27%

-50,7


-57,3


-59,7


-63,3

EPS
USD
Released
Forecast
Spread
1,32
0,38
247.59%
-0,51
-0,56
8.15%
-0,38
-0,52
27.23%
-0,10
-0,44
77.43%
-0,41
-0,45
9.03%
-0,43
-0,50
14.56%
-0,34
-0,49
30.11%
-0,40
-0,48
16.07%
-0,47
-0,50
5.37%

-0,61


-0,68


-0,71


-0,76

Announcement Date28/02/2210/05/2208/08/2207/11/2228/02/2308/05/2308/08/2308/11/2328/02/24----

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. AVIR Stock
  4. Calendar Atea Pharmaceuticals, Inc.